Cost-effectiveness of a Brief Structured Intervention Program Aimed at Preventing Repeat Suicide Attempts Among Those Who Previously Attempted Suicide: A Secondary Analysis of the ASSIP Randomized Clinical Trial
A-La Park, Anja Gysin-Maillart, Thomas J Müller, Aristomenis Exadaktylos, Konrad Michel, A-La Park, Anja Gysin-Maillart, Thomas J Müller, Aristomenis Exadaktylos, Konrad Michel
Abstract
Importance: This is the first cost-effectiveness analysis of a brief therapy, the Attempted Suicide Short Intervention Program (ASSIP), for individuals who attempt suicide.
Objective: To explore the cost-effectiveness of the ASSIP intervention in the context of the Swiss health care system.
Design, setting, and participants: In this economic evaluation, the cost-effectiveness analysis was performed from a health care perspective between January 2017 and April 2018 using data from a randomized clinical trial conducted between June 2009 and December 2014. Participants were individuals who had attempted suicide and were receiving treatment at a psychiatric university hospital in Switzerland that provides inpatient and outpatient services for suicide attempters referred from an emergency department of a general hospital.
Interventions: The intervention group received 3 manual-based therapy sessions followed by regular personalized letters over 24 months. The control group was offered a single suicide risk assessment.
Main outcomes and measures: The main economic analysis explored cost per suicide attempt avoided expressed in 2015 Swiss francs (CHF). Cost-effectiveness planes were plotted and cost-effectiveness acceptability curves calculated.
Results: One hundred twenty participants (mean [SD] age, 37.8 [14.4] years; 66 [55%] women and 54 [45%] men) were assigned to an intervention group or a control group, each with 60 participants. At 24 months of follow-up, 5 suicide attempts were reported in the ASSIP group among 59 participants with follow-up data available, and 41 were reported in the control group among 53 participants with follow-up data available. The ASSIP group had higher intervention costs, with CHF 1323 vs CHF 441 for the control group. At 24 months of follow-up, psychiatric hospital costs were lower in the ASSIP group than in the control group, although this difference was not significant (mean [SD], CHF 20 559 [38 676] vs CHF 45 488 [73 306]; mean difference, CHF -16 081; 95% CI, CHF -34 717 to 1536; P = .11). General hospital costs were significantly lower for the ASSIP group. Total health care costs were also lower, but the difference was not significant (mean [SD], CHF 21 302 [38 819] vs 41 287 [74 310]; difference, CHF -12 604; 95% CI, CHF -29 837 to 625; P = .14). In a base-case analysis, ASSIP was dominant, with significantly fewer reattempts at lower overall cost. The intervention had a 96% chance of being less costly and more effective. A sensitivity analysis showed a 96% and 95% chance of ASSIP being more effective and less costly at willingness-to-pay levels of CHF 0 and CHF 30 000, respectively.
Conclusions and relevance: The ASSIP intervention is a cost-saving treatment for individuals who attempt suicide. The findings support the use of ASSIP as a treatment for suicide attempters. Further studies are needed to determine cost-effectiveness in other contexts.
Trial registration: ClinicalTrials.gov Identifier: NCT02505373.
Conflict of interest statement
Conflict of Interest Disclosures: Drs Gysin-Maillart and Michel received royalties from Hogrefe Publishing for ASSIP—Attempted Suicide Short Intervention Program: A Manual for Clinicians. No other disclosures were reported.
Figures
References
- Fleischmann A, De Leo D. The World Health Organization’s report on suicide: a fundamental step in worldwide suicide prevention. Crisis. 2014;35(5):-. doi:10.1027/0227-5910/a000293
- Carroll R, Metcalfe C, Gunnell D. Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis. PLoS One. 2014;9(2):e89944. doi:10.1371/journal.pone.0089944
- Piscopo K, Lipari RN, Cooney JGC Suicidal thoughts and behavior among adults: results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. 2016. . Accessed April 20, 2018.
- Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm: systematic review. Br J Psychiatry. 2002;181(3):193-199. doi:10.1192/bjp.181.3.193
- Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry. 2003;182(6):537-542. doi:10.1192/bjp.182.6.537
- Shepard DS, Gurewich D, Lwin AK, Reed GA Jr, Silverman MM. Suicide and suicidal attempts in the United States: costs and policy implications. Suicide Life Threat Behav. 2016;46(3):352-362. doi:10.1111/sltb.12225
- Platt S, McLean J, McCollam A, et al. . Evaluation of the First Phase of Choose Life: The National Strategy and Action Plan to Prevent Suicide in Scotland. Edinburgh, Scotland: Scottish Executive Social Research; 2006.
- Tsiachristas A, McDaid D, Casey D, et al. . General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis. Lancet Psychiatry. 2017;4(10):759-767. doi:10.1016/S2215-0366(17)30367-X
- Czernin S, Vogel M, Flückiger M, et al. . Cost of attempted suicide: a retrospective study of extent and associated factors. Swiss Med Wkly. 2012;142:w13648.
- Hawton K, Witt KG, Salisbury TLT, et al. . Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(8):740-750. doi:10.1016/S2215-0366(16)30070-0
- Zalsman G, Hawton K, Wasserman D, et al. . Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry. 2016;3(7):646-659. doi:10.1016/S2215-0366(16)30030-X
- Inagaki M, Kawashima Y, Kawanishi C, et al. . Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt: a meta-analysis. J Affect Disord. 2015;175:66-78. doi:10.1016/j.jad.2014.12.048
- Hetrick SE, Robinson J, Spittal MJ, Carter G. Effective psychological and psychosocial approaches to reduce repetition of self-harm: a systematic review, meta-analysis and meta-regression. BMJ Open. 2016;6(9):e011024. doi:10.1136/bmjopen-2016-011024
- Bustamante Madsen L, Eddleston M, Schultz Hansen K, Konradsen F. Quality assessment of economic evaluations of suicide and self-harm interventions. Crisis. 2018;39(2):82-95. doi:10.1027/0227-5910/a000476
- Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K. A novel brief therapy for patients who attempt suicide: a 24-months follow-up randomized controlled study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med. 2016;13(3):e1001968. doi:10.1371/journal.pmed.1001968
- Husereau D, Drummond M, Petrou S, et al. ; CHEERS Task Force . Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Clin Ther. 2013;35(4):356-363. doi:10.1016/j.clinthera.2013.03.003
- Silverman MM, Berman AL, Sanddal ND, O’Carroll PW, Joiner TE. Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors, part 1: background, rationale, and methodology. Suicide Life Threat Behav. 2007;37(3):248-263. doi:10.1521/suli.2007.37.3.248
- World Health Organization The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 2014.
- Rickham PP. Human Experimentation: Code of Ethics of the World Medical Association: Declaration of Helsinki. BMJ. 1964;2(5402):177. doi:10.1136/bmj.2.5402.177
- Michel K, Gysin-Maillart A. ASSIP—Attempted Suicide Short Intervention Program: A Manual for Clinicians. Göttingen, Germany: Hogrefe Publishing; 2015. doi:10.1027/00476-000
- Bieleninik L, Geretsegger M, Mössler K, et al. ; TIME-A Study Team . Effects of improvisational music therapy vs enhanced standard care on symptom severity among children with autism spectrum disorder: the TIME-A randomized clinical trial. JAMA. 2017;318(6):525-535. doi:10.1001/jama.2017.9478
- Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171-185. doi:10.1080/01621459.1987.10478410
- Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford, UK: Oxford University Press; 2014. doi:10.1093/med/9780199685028.001.0001
- Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M. Herpes zoster vaccine: A health economic evaluation for Switzerland. Hum Vaccin Immunother. 2017;13(7):1495-1504. doi:10.1080/21645515.2017.1308987
- European Network for Health Technology Assessment Methods for Health Economic Evaluations, a Guideline Based on Current Practices in Europe. Diemen, Netherlands: European Network for Health Technology Assessment; 2015.
- National Institute for Health and Care Excellence Methods for the Development of NICE Public Health Guidance. London, UK: National Institute for Health and Care Excellence; 2012.
- Olfson M, Marcus SC, Bridge JA. Emergency treatment of deliberate self-harm. Arch Gen Psychiatry. 2012;69(1):80-88. doi:10.1001/archgenpsychiatry.2011.108
- Morthorst B, Krogh J, Erlangsen A, Alberdi F, Nordentoft M. Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trial. BMJ. 2012;345:e4972. doi:10.1136/bmj.e4972
- Owens PL, Fingar KR, Heslin K, Mutter R, Booth CL. Emergency Department Visits Related to Suicidal Ideation, 2006–2013. Rockville, MD: Agency for Healthcare Research and Quality; 2017.
- Fleischmann A, Arensman E, Berman A, et al. . Overview evidence on interventions for population suicide with an eye to identifying best-supported strategies for LMICs. Glob Ment Health (Camb). 2016;3:e5. doi:10.1017/gmh.2015.27
- Sahlin H, Kuja-Halkola R, Bjureberg J, et al. . Association between deliberate self-harm and violent criminality. JAMA Psychiatry. 2017;74(6):615-621. doi:10.1001/jamapsychiatry.2017.0338
Source: PubMed